Science Explorer Back to mapMap
Discussion
Company · Colorado Springs · United States

HemoGenix (United States)

hemogenix.comROR OpenAlex
Research works
19
fractional, all time
Citations
171
8.9 per fractional work
Top-10% rate
1.7%
all institutions 10.0%
Open access
28%
world 40%
International
3%
world 18%
HemoGenix (United States)

Not ranked overall: HemoGenix (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does HemoGenix (United States) work in?

In all years, 58% of research at HemoGenix (United States) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (58%), Biochemistry, Genetics and Molecular Biology (16%), Engineering (14%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 11 fractional works · 57.8% of its workMedicine: 11 fractional works · 57.6% of its workHematology: 3 fractional works · 18.0% of its workGenetics: 2 fractional works · 10.5% of its workOncology: 2 fractional works · 8.7% of its workPulmonary and Respiratory Medicine: 2 fractional works · 7.8% of its workPhysiology: 1 fractional works · 7.5% of its workSurgery: 1 fractional works · 2.8% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.6% of its workVeterinary: 0 fractional works · 0.2% of its workLife Sciences: 5 fractional works · 26.2% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 15.7% of its workMolecular Biology: 3 fractional works · 14.2% of its workCell Biology: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.6% of its workImmunology and Microbiology: 2 fractional works · 9.6% of its workImmunology: 2 fractional works · 9.6% of its workNeuroscience: 0 fractional works · 0.9% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.9% of its workPhysical Sciences: 3 fractional works · 16.0% of its workEngineering: 3 fractional works · 14.1% of its workBiomedical Engineering: 3 fractional works · 14.1% of its workMathematics: 0 fractional works · 1.7% of its workModeling and Simulation: 0 fractional works · 1.7% of its workComputer Science: 0 fractional works · 0.2% of its workALL ITS WORKHemoGenix (UnitedStates)19fractional works, all years
Life Sciences26%Physical Sciences16%Health Sciences58%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 8 fields, with their numbers
    1. Medicine1157.6%
    2. Veterinary00.2%
    1. Biochemistry, Genetics and Molecular Biology315.7%
    2. Immunology and Microbiology29.6%
    3. Neuroscience00.9%
    1. Engineering314.1%
    2. Mathematics01.7%
    3. Computer Science00.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from HemoGenix (United States)?

The most cited paper from HemoGenix (United States) is "Autocrine transforming growth factor-β regulation of hematopoiesis: many outcomes that depend on the context" (Francis W. Ruscetti, Salem M. Akel, Stephen H. Bartelmez, 2005), with 111 citations. Next come "Validation and Development of a Predictive Paradigm for Hemotoxicology Using a Multifunctional Bioluminescence Colony-Forming Proliferation Assay" (52) and "Emerging approaches in predictive toxicology" (37).

Most cited papers
#PaperReleasedCitations
1 Autocrine transforming growth factor-β regulation of hematopoiesis: many outcomes that depend on the context Francis W. Ruscetti, Salem M. Akel, Stephen H. Bartelmez · Oncogene 26 Aug 2005 111
2 Validation and Development of a Predictive Paradigm for Hemotoxicology Using a Multifunctional Bioluminescence Colony-Forming Proliferation Assay Ivan N. Rich, Karen M. Hall · Toxicological Sciences Open access 7 Jul 2005 52
3 Emerging approaches in predictive toxicology Luoping Zhang, Cliona M. McHale, Nigel Greene et al. · Environmental and Molecular Mutagenesis Open access 9 Jul 2014 37
4 Improving Quality and Potency Testing for Umbilical Cord Blood: A New Perspective Ivan N. Rich · Stem Cells Translational Medicine Open access 9 Jul 2015 25
5 In vitro hematotoxicity testing in drug development: a review of past, present and future applications. Ivan N. Rich · PubMed 2003 20
All 24 most cited papers, with filters and sorting

Which research topics does HemoGenix (United States) publish most on?

By volume in 2022-now: Corneal Surgery and Treatments, Reproductive System and Pregnancy, Cell Adhesion Molecules Research and Mesenchymal stem cell research.

Corneal Surgery and Trea…0Corneal Surgery and Treatments: 0 fractional worksReproductive System and …0Reproductive System and Pregnancy: 0 fractional worksCell Adhesion Molecules …0Cell Adhesion Molecules Research: 0 fractional works
Radiology, Nuclear Medicine and ImagingImmunologyImmunology and Allergy

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Corneal Surgery and Treatments Radiology, Nuclear Medicine and Imaging 0 works
  2. 2 Reproductive System and Pregnancy Immunology 0 works
  3. 3 Cell Adhesion Molecules Research Immunology and Allergy 0 works
  4. 4 Mesenchymal stem cell research Genetics 0 works
  5. 5 Pluripotent Stem Cells Research Molecular Biology 0 works
  6. 6 Tissue Engineering and Regenerative Medicine Surgery 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available27.5%not open72.5%

World: 40% of research is openly available.

with international co-authors3.2%domestic only96.8%

World: 18% is written across borders.

How has HemoGenix (United States)'s research output changed?

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is HemoGenix (United States) as a percentage of every work published that year, 0.0000015% in 2023.

still counting0.00010%0.00020%HemoGenix (United States)0.0000085% in 202520102020

Fractional works of HemoGenix (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Colorado Springs

All research institutions in Colorado Springs

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about HemoGenix (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.